LIGABUE, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 9.575
EU - Europa 8.175
AS - Asia 4.572
SA - Sud America 590
Continente sconosciuto - Info sul continente non disponibili 149
AF - Africa 124
OC - Oceania 14
Totale 23.199
Nazione #
US - Stati Uniti d'America 9.316
IT - Italia 4.907
SG - Singapore 1.345
CN - Cina 1.254
DE - Germania 813
GB - Regno Unito 780
VN - Vietnam 512
HK - Hong Kong 479
BR - Brasile 430
SE - Svezia 374
RU - Federazione Russa 280
BD - Bangladesh 257
NL - Olanda 209
FR - Francia 199
FI - Finlandia 172
KR - Corea 149
CA - Canada 141
IN - India 114
TR - Turchia 92
ID - Indonesia 85
UA - Ucraina 84
AR - Argentina 62
MX - Messico 59
BG - Bulgaria 53
JP - Giappone 48
ES - Italia 44
IQ - Iraq 37
PL - Polonia 32
ZA - Sudafrica 32
CH - Svizzera 29
PK - Pakistan 27
MA - Marocco 26
BE - Belgio 23
CZ - Repubblica Ceca 22
MY - Malesia 22
IE - Irlanda 21
AT - Austria 19
IR - Iran 19
EC - Ecuador 18
VE - Venezuela 18
CO - Colombia 17
AE - Emirati Arabi Uniti 16
LT - Lituania 16
CL - Cile 15
PE - Perù 14
CR - Costa Rica 13
PT - Portogallo 13
UZ - Uzbekistan 13
AU - Australia 12
DZ - Algeria 12
IL - Israele 12
RO - Romania 12
AZ - Azerbaigian 11
EG - Egitto 11
KE - Kenya 10
PH - Filippine 10
TW - Taiwan 10
AL - Albania 9
JM - Giamaica 9
PY - Paraguay 9
SA - Arabia Saudita 9
TN - Tunisia 9
DK - Danimarca 8
DO - Repubblica Dominicana 8
JO - Giordania 8
MT - Malta 8
SI - Slovenia 8
BY - Bielorussia 7
KZ - Kazakistan 7
NO - Norvegia 6
NP - Nepal 6
PA - Panama 6
TT - Trinidad e Tobago 6
NG - Nigeria 5
RS - Serbia 5
GR - Grecia 4
HR - Croazia 4
MD - Moldavia 4
NI - Nicaragua 4
OM - Oman 4
BB - Barbados 3
BH - Bahrain 3
BO - Bolivia 3
GE - Georgia 3
GT - Guatemala 3
KH - Cambogia 3
SC - Seychelles 3
SV - El Salvador 3
TH - Thailandia 3
UY - Uruguay 3
EU - Europa 2
HN - Honduras 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
MC - Monaco 2
MK - Macedonia 2
MZ - Mozambico 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
Totale 23.023
Città #
Ashburn 1.076
Singapore 868
Santa Clara 790
San Jose 627
Fairfield 548
Hong Kong 462
Southend 459
Milan 446
Hefei 428
Chandler 392
Council Bluffs 362
Rome 333
Woodbridge 291
Houston 263
Seattle 219
Cambridge 205
Wilmington 205
Beijing 203
Nyköping 187
Ann Arbor 168
London 167
Ho Chi Minh City 162
Naples 154
New York 150
Jacksonville 147
Los Angeles 145
Seoul 139
Dearborn 133
Hanoi 126
Modena 123
Helsinki 116
Dallas 98
Bologna 91
The Dalles 89
Bari 74
Turin 74
Munich 73
Florence 68
Chicago 66
Frankfurt am Main 63
Lauterbourg 62
Buffalo 59
São Paulo 54
Jakarta 53
Moscow 53
San Diego 51
Parma 50
Phoenix 49
Princeton 47
Sofia 47
Catania 45
Orem 44
Shanghai 44
Atlanta 41
Palermo 40
Izmir 39
Toronto 37
Tokyo 36
Genoa 35
Columbus 33
Verona 33
Brescia 32
Eugene 32
Fremont 32
Montreal 31
Nuremberg 31
Des Moines 29
Redwood City 29
Reggio Emilia 29
Denver 26
Padova 25
Warsaw 25
Boardman 24
Falls Church 24
Guangzhou 24
Cagliari 23
Brooklyn 22
Kent 22
Da Nang 21
Lucca 21
Salerno 21
Livorno 20
Monza 20
Turku 20
Mexico City 19
Salt Lake City 19
Durham 18
Venice 18
Amsterdam 17
Bremen 17
Tampa 17
Baghdad 16
Brussels 16
Haiphong 16
Perugia 16
Poplar 16
Chennai 15
Dublin 15
Norwalk 15
Wuhan 15
Totale 12.590
Nome #
Effetto della N-acetilcisteina sulla progressione dell'insufficienza renale cronica nel ratto 4.346
The Role of PEC Progenitors in ADPKD Progression 1.117
Clinical outcome of kidney transplantation in HIV-infected recipients: a retrospective study 450
Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy 434
CD133 and CD24 expression in renal tissue of patients affected by autosomal dominant polcystic kidney disease 427
Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers 413
Activation of coagulation during hemodialysis: Effect of blood lines alone and whole extracorporeal circuit 400
Evaluation of a system for sorbent-assisted peritoneal dialysis in a uremic pig model 389
Evaluation of the Classification Accuracy of the Kidney Biopsy Direct Immunofluorescence through Convolutional Neural Networks 380
The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition 379
Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images 378
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 378
GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a Modified Atkins Diet in Autosomal Dominant Polycystic Kidney Disease patients 373
Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library 370
Confidence Calibration for Deep Renal Biopsy Immunofluorescence Image Classification 369
P-Cresol and Cardiovascular Risk in Kidney Transplant Recipients 365
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 349
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 341
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 340
Il rene policistico autosomico dominante (ADPKD): aspetti genetico-molecolari, clinici ed epidemiologici nella provincia di Modena. 323
I polimorfismi del gene dell’enzima di conversione dell’angiotensina (ACE) nel rene policistico autosomico dominante (ADPKD) 319
[Dyslipidemia and the risk of kidney disease]. 304
Water treatment and monitor disinfection 297
Relapse of atypical hemolytic uremic syndrome during pregnancy in a patient on eculizumab maintenance treatment: A case report 292
A validated model of disease progression in IgA nephropathy 288
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease 286
Detection of predictive urinary biomarkers of nephropathy in type 1 and type 2 diabetes by proteomic analysis 284
Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin 284
Acid base disorders in patients with COVID-19 284
Assessing middle-molecular and protein-bound uremic toxins: a six month study of ATA vs PS membranes in hemodiafiltration 280
#5187 GREASE II: A PHASE II RANDOMIZED, 24-MONTH, PARALLEL-GROUP, SUPERIORITY STUDY TO EVALUATE THE EFFICACY OF A KETOGENIC DIET IN ADPKD PATIENTS 273
In vitro efficacy and safety of a system for sorbent-assisted peritoneal dialysis 272
Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease 261
Post-transplant recurrence of glomerulonephritis: a complex clinical case. 255
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 255
P-cresolo solfato e rischio cardiovascolare nel paziente trapiantato 253
COVID-19 Rapid Antigen Test Screening in Patients on Hemodialysis 251
The underlying cause of kidney disease is often unknown in dialysis patients: a possible genomic approach 250
Interstitiome: a novel proteomic discipline applied to renal biopsy 248
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19 247
FP808EARLY IDENTIFICATION OF SICKLE CELL NEPHROPATHY IN A COHORT OF CHILDREN WITH SICKLE CELL DISEASE 245
Influence of dialysate temperature on creatinine peritoneal clearance in peritoneal dialysis patients: a randomized trial 242
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients. 239
Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study 232
Combining telemedicine and in-person visits to deliver care to patients with severe chronic kidney disease (CKD): Lessons learned from COVID-19 232
Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single-Center Study 226
Immunosuppressive therapy reduction and early post-infection graft function in kidney transplant recipients with COVID-19 214
Risk of infections related to endovascular catheters and cardiac implantable devices in hemodialysis patients 211
Weekly Rapid Antigen Test Screening for COVID-19 in Patients on Hemodialysis 210
AKI in hospitalized patients with COVID-19: a single-center experience 200
Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19 190
Rethinking Chronic Kidney Disease in the Aging Population 189
Reversed high-flux SUPRA HFR: a proof of concept pilot study to access the middle molecular weight uremic toxins 185
Towards the monitoring of dialysis treatment through absorption and endogenous fluorescence techniques 165
Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study 159
Il centro dialisi ecosostenibile 155
Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants 154
Middle-Molecular Weight Toxin Removal: Asymmetric Cellulose Triacetate vs. Helicoidal Polysulfone during Online Hemodiafiltration (CHORALS Study) 148
Screening for nasal carriage of Staphylococcus (S.) aureus reduces the risk of S. aureus peritonitis in patients on peritoneal dialysis (PD) 146
Rationale and design of the CORDIAL first-in-human clinical trial: a system for sorbent-assisted continuous flow peritoneal dialysis 145
Improving the sustainability and quality of kidney health care through life cycle assessments, quality improvement, education and technical innovations: the KitNewCare approach 141
Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients: a single-center experience 139
Migrants on hemodialysis (HD): clinical characteristics, outcome and quality of life 135
Long-term mortality and technique survival in peritoneal dialysis patients: a 25-year retrospective analysis in a single center 125
Formative usability test of a novel device for peritoneal dialysis (WEAKID) 118
Diagnostic Yield and Clinical Impact of a Small Genetic Panel for Kidney Disease: A Multicenter, Retrospective European Study 111
A life cycle assessment of peritoneal dialysis procurement in Italy: environmental burden and opportunities for improvement 103
Validation of Hemoglobin and Hematocrit Measurements from a Dialysis Machine Sensor Compared to Laboratory Analysis: A Cross-Sectional Study 101
Intradialytic clearances and reduction ratios for middle molecular weight uremic toxins and protein-bound uremic toxins: comparison of hemodiafiltration with asymmetric cellulose triacetate vs hemodiafiltration with helycoidal polysulfone during a 6-month follow-up 101
Sustainable kidney care: A life cycle assessment of the peritoneal dialysis pathways 73
Rationale and design of the CORDIAL first-in-human clinical trial: A system for sorbent-assisted continuous flow peritoneal dialysis 58
Comparing environmental footprints of haemodialysis and online haemodiafiltration in Italy 49
#2314 Greenhouse gas emissions from the special waste incineration: a comparative analysis between a large Dialysis Center and a University Hospital 46
Green haemodialysis: comparison of dialysis bags versus fresenius granumix at the AOU Policlinico di Modena, Italy 46
Continuous Flow Peritoneal Dialysis 43
Twelve-Month Evaluation of Middle Molecule (MMUT) and Protein-Bound Uremic Toxin (PBUT) Removal with Two Different Hemodiafiltration Filters 42
Theoretically redesigning peritoneal dialysis products for sustainability: A life cycle inventory approach 38
Genomic Approaches for Monogenic Kidney Diseases: A Comparative Review of Diagnostic Methods and Precision Medicine Implications 25
Environmental footprint of peritoneal dialysis in Europe: a comparative life cycle assessment across four European centres 13
Toward a Patient-Specific Model of Protein-Bound Uremic Toxin Kinetics during Online Haemodiafiltration 1
Totale 23.199
Categoria #
all - tutte 74.567
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.567


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022888 0 0 0 110 50 98 53 54 107 77 213 126
2022/20231.981 126 173 94 171 168 274 136 216 189 113 179 142
2023/20242.501 111 118 200 244 291 246 302 255 119 181 201 233
2024/20254.429 245 232 230 345 624 605 401 281 435 202 375 454
2025/20267.454 454 295 498 694 828 383 864 334 680 699 1.422 303
2026/20271.808 455 592 489 272 0 0 0 0 0 0 0 0
Totale 23.199